Lifecore Biomedical, Inc. Common Stock LFCR
$6.52
+55.24%
at last close
Market Cap$158.98 million
P/E Ratio—
Div Yield—
Volume4.01M
52-Week Range
$3.63$8.98
Analyst Ratings
- Consensus
- Moderate Buy — 1 Buy · 1 Hold · 0 Sell (2 analysts)
- Avg. Price Target
- $6.50 (-0.3% downside)
Key Stats
- Today's Range
- $6.40 – $6.65
- 50-Day Range
- $4.00 – $6.65
- 52-Week Range
- $3.63 – $8.98
- Volume
- 4.01 million shs
- Average Volume
- 268K shs
- Market Cap
- $158.98 million
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- -4.66
- Price / Sales
- —
Short Interest
- Short Interest
- 0.90%
- Days to Cover
- 7.66
About Lifecore Biomedical, Inc. Common Stock
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.
Related Stocks
Compare head-to-head: LFCR vs LLY·LFCR vs JNJ·LFCR vs ABBV·LFCR vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.